Quantcast
Last updated on June 2, 2012 at 14:15 EDT

    News - Abraxis Bioscience Inc.

    Reportlinker Adds World Cancer Therapies Market Report
    2009-09-10 07:46:00

    NEW YORK, Sept.

    Reportlinker Adds Nanomedicine Report
    2009-09-08 08:31:00

    NEW YORK, Sept.

    Abraxis BioScience and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia
    2008-10-16 09:00:10

    Abraxis BioScience, Inc.

    Abraxis BioScience Names Edward Geehr, M.D., Executive Vice President of Operations
    2008-10-14 09:00:45

    Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that Edward C. Geehr, M.D., has joined the company as Executive Vice President of Operations. Dr.

    Cenomed and TorreyPines Therapeutics Enter into Licensing Agreement
    2008-10-08 09:00:36

    Cenomed BioSciences, LLC, a majority-owned subsidiary of Abraxis BioScience, Inc. (Nasdaq: ABII), and TorreyPines Therapeutics, Inc.

    More News (43 articles) »
    Breaking News
    Space
    Science
    Technology
    Health
    CES 2012
    More...
    Streaming Video
    Top Picks
    Science
    Health
    More...
    Images and Photos
    Images of the Day
    Image Galleries
    Wallpapers
    More...
    Space Exploration
    Astronomy
    Human Spaceflight
    Ask the Astronomer
    More...
    Science and Research
    Instruments
    Calculator
    Ask the Scientist
    More...
    Technology
    Ask the Expert
    Technology Reviews
    More...
    My Health
    Health
    More...
    © 2002-2012 redOrbit.com. All rights reserved
    All other copyrights remain the property of their respective owners